Verge Medical

Executive Summary

Verge Medical is a private medical device company developing physician-driven solutions for challenging vascular interventions. Its flagship product, the FLASH™ Aorto-Ostial Angioplasty System, is a novel dual-balloon catheter designed to optimize stent placement at vessel openings (ostia), addressing a critical unmet need in interventional cardiology. The FLASH system aims to improve procedural accuracy and reduce complications such as stent malposition and restenosis in aorto-ostial lesions, which are notoriously difficult to treat with conventional balloon catheters. Founded in 2018 and headquartered in San Diego, the company has focused on innovation in the vascular space, targeting both coronary and peripheral markets. Through strategic acquisitions, Verge Medical has expanded its portfolio to include peripheral embolic protection devices and other technologies, broadening its market reach beyond coronary applications. The company is positioned to capture share in the growing vascular intervention market, driven by aging demographics and increasing prevalence of cardiovascular disease. With a pipeline of physician-inspired solutions, Verge is poised for commercialization and regulatory milestones that could drive significant value creation. Its private status allows for focused R&D and potential strategic partnerships or acquisition interest from larger medical device players.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for FLASH Aorto-Ostial Angioplasty System75% success
• Q2 2027Publication of pivotal clinical study results for FLASH system60% success
• Q1 2027Commercial expansion into peripheral embolic protection market via acquired technology65% success